#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Neonatal alloimmune thrombocytopenia Infertility female Metastases to peritoneum Adenocarcinoma pancreas Short stature Hereditary haemorrhagic telangiectasia Mantle cell lymphoma stage IV Craniocerebral injury Skin angiosarcoma Li-Fraumeni syndrome Uterine leiomyosarcoma Hidradenitis Hepatoblastoma Chronic myelomonocytic leukaemia More trials…

    Learn about Rare Diseases

    Skin angiosarcoma – Life with Disease Anaplastic thyroid cancer – Trials in Disease Phenylketonuria – Life with Disease Primary immunodeficiency syndrome – Diagnostics Hereditary motor and sensory neuropathy – Trials in Disease Cystic fibrosis lung – Treatment Mantle cell lymphoma refractory – Treatment Osteosarcoma – Basic Information Hepatic angiosarcoma – Basic Information Pleural mesothelioma malignant – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clobetasol Propionate Andexanet Alfa Dried Ferrous Sulfate Betamethasone Valerate Cabotegravir SARACATINIB AGA2118 Dantrolene Sodium Zanamivir Ag-946 Phosphate Brepocitinib Tosilate Gefurulimab Nirmatrelvir Sultiame Protamine Sulfate Bulevirtide Relatlimab AZD0292 Levosimendan Vemurafenib More therapies…

    Learn about Your Condition

    Breast cancer stage IV Thermal burn Still's disease Aortic valve disease Colorectal cancer Mitral valve prolapse Tourette's disorder Hypoaesthesia Stem cell transplant Lower limb fracture Cutibacterium acnes infection Partial lipodystrophy Procedural pain Metastasis Ichthyosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Eye Diseases

  • Study on the Effectiveness of Bevacizumab and Ranibizumab in Treating Age-Related Macular Degeneration in Patients with Genetic Variations

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Age-related macular degeneration
    Investigated Drugs:
    • Ranibizumab
    • Bevacizumab
    Spain

  • Study on the Safety and Tolerability of VRDN-001 for Patients with Thyroid Eye Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Endocrine ophthalmopathy
    Investigated Drugs:
    • Vrdn-001
    France Germany The Netherlands Poland Spain

  • Study on Preventing Arterial Calcification in Young Patients with Pseudoxanthoma Elasticum Using Etidronate

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pseudoxanthoma elasticum
    Investigated Drugs:
    • Etidronate Disodium
    The Netherlands

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Diabetic retinal oedema
    • Macular oedema
    Investigated Drugs:
    • Eye103
    • Ranibizumab
    • Fluorescein Sodium
    Austria Croatia Czechia France Germany Hungary +6

  • Study of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease

    Not recruiting

    2 1
    Investigated Drugs:
    • AMG 732
    France Germany Greece Italy Poland Spain

  • Study on Long-term Safety and Effectiveness of Bimatoprost SR for Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    France Germany Poland Spain
Previous Page
1 … 35 36 37

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!